[INSULIN RESISTANCE ASSOCIATED WITH METABOLIC SYNDROME AS AN INDICATOR OF CARDIOVASCULAR RISK]

Klinicheskaia Meditsina
|August 16, 2016
PubMed

Insights

Metabolic syndrome significantly elevates blood insulin levels and insulin resistance in coronary heart disease (CHD) patients. This indicates increased cardiovascular risk due to associated factors like dyslipidemia and inflammation.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Biochemistry

Background:

  • Coronary heart disease (CHD) poses a significant global health burden.
  • Metabolic syndrome (MS) is increasingly recognized as a major risk factor for cardiovascular diseases.
  • Understanding the interplay between MS, insulin levels, and cardiovascular risk factors in CHD patients is crucial.

Purpose of the Study:

  • To investigate blood insulin levels in patients with CHD, comparing those with and without MS.
  • To examine the relationship between insulin levels, insulin resistance, and various cardiovascular risk factors in CHD patients.

Main Methods:

  • A cohort of 127 stable CHD patients (63 with MS, 64 without MS) and 80 healthy controls were studied.
  • Blood insulin, glycated hemoglobin (HbA1c), lipids (total cholesterol, HDL, triglycerides), and inflammatory markers (oxidized LDL, IL-1β, IL-6, TNF-α) were measured.
  • Insulin resistance was assessed using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index, and depression was evaluated using the Zung scale.

Main Results:

  • CHD patients with MS exhibited significantly higher blood insulin levels (15.5 mcIE/ml) compared to those without MS (9.5 mcIE/ml) and healthy controls (6.3 mcIE/ml) (p < 0.001).
  • HOMA-IR showed a direct correlation with waist circumference, HbA1c, total cholesterol, triglycerides, oxidized LDL, IL-1β, IL-6, and TNF-α.
  • HOMA-IR demonstrated a negative correlation with HDL cholesterol levels.

Conclusions:

  • Metabolic syndrome in CHD patients is associated with hyperinsulinemia, insulin resistance, elevated HbA1c, dyslipidemia, and increased pro-inflammatory cytokines.
  • The strong correlation between HOMA-IR and key pathogenetic factors suggests its utility as a cardiovascular risk indicator in CHD patients with MS.
  • These findings highlight the complex metabolic dysregulation in CHD patients with MS and underscore the need for comprehensive risk management.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
830
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.6K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K